Patients with neuromuscular disease frequently have comorbid sleep disorders. Hypoventilation, upper airway issues, central apnoeas and paroxysmal leg movements are all common in this patient population. It is imperative that these patients undergo a formal evaluation. However, the COVID-19 pandemic has presented many challenges that have necessitated adaptations in the provision of their care. Despite the hurdles created by infection control measures to completing evaluations, such as polysomnography and advanced pulmonary function testing, they generally can be accomplished in a safe manner. Care providers should exhibit caution to avoid the temptation to make clinical decisions based on substandard testing or prescribe suboptimal therapies in this population of patients. Finally, the challenges of the pandemic have also affected the availability of in-person clinical follow-up and assessment of treatment efficacy. The utility of telehealth in this manner has proven invaluable and has allowed for reliable high-quality care to be delivered to a potentially vulnerable population of patients.
Sleep disorders, neuromuscular disease, COVID-19, pandemic, adaptations.
Access all of the content
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!